Researchers are investigating proteins in breast milk and blood serum as potential early detection biomarkers for breast cancer.

The goal is to develop a noninvasive biomarker panel for earlier diagnosis, improving prognosis and treatment outcomes.

Proteomics is used to identify specific proteins or protein groups associated with breast cancer, focusing on those linked to tumor development and disease progression.

The research aims to enable breast cancer screening for all women, potentially transforming early detection and saving lives.